Venous Thrombosis in Multiple Sclerosis Patients after High-Dose Intravenous Methylprednisolone: The Preventive Effect of Enoxaparin
Authors:
Open Access
- 25 December 2011
- journal article
- research article
- Published by Hindawi Limited in Thrombosis
- Vol. 2011, 1-4
Abstract
Aim. This study was designed to examine the possible role of high-dose intravenous methylprednisolone (IVMP) in the development of venous thrombosis (VT). The cerebral one anecdotally had been reported in patients with relapsing remitting multiple sclerosis (RRMS) in acute attacks and the possible preventive role of enoxaparin. Material and Methods. From a pool of 520 patients, 388 patients with definite RRMS who fulfilled entry characteristics were selected and randomly received either a 5-day course of daily 1 gr IVMP or the aforementioned plus 5 days of daily subcutaneous 40 units of enoxaparin according to a predefined protocol. Results. Mean age, gender ratio, mean relapse rate, and EDSS were similar in both groups of patients (P > 0.05). Finally, 366 patients remained in the study. Of 188 patients treated with IVMP with 855 relapses, 5 developed VT (0.37% per patient per year and 0.58% per each course of IVMP) within 3 to 15 days of starting therapy. None of the 178 patients who experienced 809 relapses who received IVMP plus enoxaparin developed such complications. Conclusion. The study implies that high-dose IVMP in MS exacerbation may increase the risk of VT and prophylactic anticoagulant treatment in this setting is warranted.Keywords
This publication has 30 references indexed in Scilit:
- Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage studyBMC Medicine, 2011
- Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid‐induced increase in von Willebrand factor: the lesson learned from Cushing syndromeBritish Journal of Haematology, 2007
- Interferon Beta-1a and Intravenous Immunoglobulin Treatment for Multiple Sclerosis in IranEuropean Neurology, 2004
- Histocompatibility antigen (HLA) associations with multiple sclerosis in IranMultiple Sclerosis Journal, 2000
- Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosisJournal of Neurology, Neurosurgery & Psychiatry, 1997
- Factor V Leiden Mutation in Cerebral Venous ThrombosisStroke, 1996
- Long-term Prognosis in Cerebral Venous ThrombosisStroke, 1996
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- Primary cerebral venous thrombosis in young adults: The diverse manifestations of an underrecognized diseaseAnnals of Neurology, 1978
- Thromboembolic Complications, Heparin Treatment and Increase in Coagulation Factors in Cushing's SyndromeActa Medica Scandinavica, 1976